Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan Saul

Showing results (111-120 of 122) with videos related to

Pageof 13
Sort By:
Plos One|February 14, 2008
Phase 1 study of a combination AMA1 blood stage malaria vaccine in Malian childrenAlassane Dicko, Issaka Sagara, Ruth D Ellis, et al.
Infection and Immunity|April 23, 2004
Human leukocyte antigen class II alleles influence levels of antibodies to the Plasmodium falciparum asexual-stage apical membrane antigen 1 but not to merozoite surface antigen 2 and merozoite surface protein 1Armead H Johnson, Rose G F Leke, Nancy R Mendell, et al.
Infection and Immunity|May 24, 2005
Phase 1 clinical trial of apical membrane antigen 1: an asexual blood-stage vaccine for Plasmodium falciparum malariaElissa M Malkin, David J Diemert, Julie H McArthur, et al.
Plos Clinical Trials|April 7, 2007
Phase 1 study of two merozoite surface protein 1 (MSP1(42)) vaccines for Plasmodium falciparum malariaElissa Malkin, Carole A Long, Anthony W Stowers, et al.
Plos One|July 10, 2008
Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51Yimin Wu, Ruth D Ellis, Donna Shaffer, et al.
Plos One|October 18, 2007
Impact of a Plasmodium falciparum AMA1 vaccine on antibody responses in adult MaliansAlassane Dicko, David J Diemert, Issaka Sagara, et al.
Malaria Journal|October 11, 2007
Induction of multi-antigen multi-stage immune responses against Plasmodium falciparum in rhesus monkeys, in the absence of antigen interference, with heterologous DNA prime/poxvirus boost immunizationGeorge Jiang, Yupin Charoenvit, Alberto Moreno, et al.
Eclinicalmedicine|August 25, 2021
Efficacy, safety, and immunogenicity of the <i>Shigella sonnei</i> 1790GAHB GMMA candidate vaccine: Results from a phase 2b randomized, placebo-controlled challenge study in adultsRobert W Frenck, Valentino Conti, Pietro Ferruzzi, et al.
Vaccine|May 12, 2009
A randomized controlled phase 2 trial of the blood stage AMA1-C1/Alhydrogel malaria vaccine in children in MaliIssaka Sagara, Alassane Dicko, Ruth D Ellis, et al.
Vaccine|January 9, 2016
The transfer and decay of maternal antibody against Shigella sonnei in a longitudinal cohort of Vietnamese infantsCorinne N Thompson, Thi Phuong Tu Le, Katherine L Anders, et al.
Pageof 13

Showing results (111-120 of 122) with videos related to

Sort By:
Pageof 13
Plos One|February 14, 2008
Phase 1 study of a combination AMA1 blood stage malaria vaccine in Malian childrenAlassane Dicko, Issaka Sagara, Ruth D Ellis, et al.
Infection and Immunity|April 23, 2004
Human leukocyte antigen class II alleles influence levels of antibodies to the Plasmodium falciparum asexual-stage apical membrane antigen 1 but not to merozoite surface antigen 2 and merozoite surface protein 1Armead H Johnson, Rose G F Leke, Nancy R Mendell, et al.
Infection and Immunity|May 24, 2005
Phase 1 clinical trial of apical membrane antigen 1: an asexual blood-stage vaccine for Plasmodium falciparum malariaElissa M Malkin, David J Diemert, Julie H McArthur, et al.
Plos Clinical Trials|April 7, 2007
Phase 1 study of two merozoite surface protein 1 (MSP1(42)) vaccines for Plasmodium falciparum malariaElissa Malkin, Carole A Long, Anthony W Stowers, et al.
Plos One|July 10, 2008
Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51Yimin Wu, Ruth D Ellis, Donna Shaffer, et al.
Plos One|October 18, 2007
Impact of a Plasmodium falciparum AMA1 vaccine on antibody responses in adult MaliansAlassane Dicko, David J Diemert, Issaka Sagara, et al.
Malaria Journal|October 11, 2007
Induction of multi-antigen multi-stage immune responses against Plasmodium falciparum in rhesus monkeys, in the absence of antigen interference, with heterologous DNA prime/poxvirus boost immunizationGeorge Jiang, Yupin Charoenvit, Alberto Moreno, et al.
Eclinicalmedicine|August 25, 2021
Efficacy, safety, and immunogenicity of the <i>Shigella sonnei</i> 1790GAHB GMMA candidate vaccine: Results from a phase 2b randomized, placebo-controlled challenge study in adultsRobert W Frenck, Valentino Conti, Pietro Ferruzzi, et al.
Vaccine|May 12, 2009
A randomized controlled phase 2 trial of the blood stage AMA1-C1/Alhydrogel malaria vaccine in children in MaliIssaka Sagara, Alassane Dicko, Ruth D Ellis, et al.
Vaccine|January 9, 2016
The transfer and decay of maternal antibody against Shigella sonnei in a longitudinal cohort of Vietnamese infantsCorinne N Thompson, Thi Phuong Tu Le, Katherine L Anders, et al.
Pageof 13